08.21.12
Sequence, Inc. and PCI, LLC have opened a new office in the Innovation District of Boston, MA. The two companies plan to extend service offerings to new and existing clients in the New England biotech and pharmaceutical sectors.
"The coupling of validation and calibration services presents our clients with a streamlined approach to quality. It will reduce cost and expedite time to market for life-saving drugs benefiting our customers and patients alike. We are proud to partner with PCI, a firm well known as the distinguished leader in calibration services," said Mike Putnam, Sequence’s president.
"For some time now, a New England presence has been a key part of our expansion plans," said Andy Ferrell, president of PCI. "We believe our services will be of great value to this region's life science community. Partnering with a validation firm that has high moral standards and values similar to ours is very attractive. We look forward to partnering with Sequence and see this as a great opportunity for our firms to offer comprehensive, highly valued service solutions."
"The coupling of validation and calibration services presents our clients with a streamlined approach to quality. It will reduce cost and expedite time to market for life-saving drugs benefiting our customers and patients alike. We are proud to partner with PCI, a firm well known as the distinguished leader in calibration services," said Mike Putnam, Sequence’s president.
"For some time now, a New England presence has been a key part of our expansion plans," said Andy Ferrell, president of PCI. "We believe our services will be of great value to this region's life science community. Partnering with a validation firm that has high moral standards and values similar to ours is very attractive. We look forward to partnering with Sequence and see this as a great opportunity for our firms to offer comprehensive, highly valued service solutions."